Cargando…

The prominent role of a CDR1 somatic hypermutation for convergent IGHV3-53/3-66 antibodies in binding to SARS-CoV-2

In the fight against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), monoclonal antibodies (mAbs) serve as key strategies for the rapid prevention and treatment of COVID-19. However, analysis to fully characterize functional SARS-CoV-2 mAbs is still needed. In this study, by interrogat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Xiaolong, Zhu, Xiaoyi, Song, Wenping, Yang, Zhenlin, Wu, Yanling, Ying, Tianlei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Coronaviruses
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045774/ https://www.ncbi.nlm.nih.gov/pubmed/35380101 http://dx.doi.org/10.1080/22221751.2022.2063074

Ejemplares similares

Shared IGHV1-69-encoded neutralizing antibodies contribute to the emergence of L452R substitution in SARS-CoV-2 variants
por: Yan, Qihong, et al.
Publicado: (2022)

Evidence of somatic hypermutation in the antigen binding sites of patients with CLL harboring IGHV genes with 100% germline identity
por: Sofou, Electra, et al.
Publicado: (2022)

Association of an IGHV3-66 gene variant with Kawasaki disease
por: Johnson, Todd A., et al.
Publicado: (2020)

Correlations in Somatic Hypermutation Between Sites in IGHV Genes Can Be Explained by Interactions Between AID and/or Polη Hotspots
por: Krantsevich, Artem, et al.
Publicado: (2021)

Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain
por: Tan, Timothy J.C., et al.
Publicado: (2021)

Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2
por: Zhang, Qi, et al.
Publicado: (2021)

Single-Step IGHV Next-Generation Sequencing Detects Clonality and Somatic Hypermutation in Lymphoid Malignancies: A Phase III Diagnostic Accuracy Study
por: Gazzola, Anna, et al.
Publicado: (2023)

Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
por: Mansouri, Larry, et al.
Publicado: (2022)

FACT and H3.3: New markers for the somatic hypermutation
por: Aida, Masatoshi, et al.
Publicado: (2013)

Germline variants of IGHV3-53 / V3-66 are determinants of antibody responses to the BNT162b2 mRNA COVID-19 vaccine
por: Mashimo, Yoichi, et al.
Publicado: (2022)

Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
por: Mansouri, Larry, et al.
Publicado: (2023)

Tandem Substitutions in Somatic Hypermutation
por: Sepúlveda-Yáñez, Julieta H., et al.
Publicado: (2022)

Identification of TMEM53 as a novel SADS-CoV restriction factor that targets viral RNA-dependent RNA polymerase
por: Yao, Yu-Lin, et al.
Publicado: (2023)

Structure of the multiple functional domains from coronavirus nonstructural protein 3
por: Li, Mengxia, et al.
Publicado: (2021)

SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species
por: Moustaqil, Mehdi, et al.
Publicado: (2021)

Attracting AID to targets of somatic hypermutation
por: Tanaka, Atsushi, et al.
Publicado: (2010)

AID function in somatic hypermutation and class switch recombination: AID function in somatic hypermutation and class switch recombination
por: Yu, Kefei
Publicado: (2022)

Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade
por: Cloherty, Alexandra P. M., et al.
Publicado: (2023)

Increase over time of antibody levels 3 months after a booster dose as an indication of better protection against Omicron infection
por: Bingula, Rea, et al.
Publicado: (2023)

HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19
por: Wang, Ruihua, et al.
Publicado: (2023)

3D Ex vivo tissue platforms to investigate the early phases of influenza a virus- and SARS-CoV-2-induced respiratory diseases
por: Schloer, Sebastian, et al.
Publicado: (2022)

Induction of significant neutralizing antibodies against SARS-CoV-2 by a highly attenuated pangolin coronavirus variant with a 104nt deletion at the 3'-UTR
por: Lu, Shanshan, et al.
Publicado: (2022)

Orthogonal dual reporter-based gain-of-signal assay for probing SARS-CoV-2 3CL protease activity in living cells: inhibitor identification and mutation investigation
por: Bei, Zhu-Chun, et al.
Publicado: (2023)

Molecular features of IGHV3-53-encoded antibodies elicited by SARS-CoV-2
por: Fagiani, Francesca, et al.
Publicado: (2020)

Switch recombination and somatic hypermutation are controlled by the heavy chain 3′ enhancer region
por: Dunnick, Wesley A., et al.
Publicado: (2009)

Identifying protein–protein interactions in somatic hypermutation
por: Goodman, Myron F., et al.
Publicado: (2005)

Recurrent targets of aberrant somatic hypermutation in lymphoma
por: Khodabakhshi, Alireza Hadj, et al.
Publicado: (2012)

A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants
por: Pérez-Vargas, Jimena, et al.
Publicado: (2023)

Immunogenicity and safety of Biological E’s CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a phase-3, single blind, multicentre, randomized clinical trial
por: Thuluva, Subhash, et al.
Publicado: (2023)

A Role for Msh6 But Not Msh3 in Somatic Hypermutation and Class Switch Recombination
por: Martomo, Stella A., et al.
Publicado: (2004)

Somatic hypermutation of an immunoglobulin mu heavy chain transgene
Publicado: (1993)

The Role of DNA Repair in Somatic Hypermutation of Immunoglobulin Genes
por: Kim, Nayun, et al.
Publicado: (1998)

UNG shapes the specificity of AID-induced somatic hypermutation
por: Pérez-Durán, Pablo, et al.
Publicado: (2012)

Checkpoint kinase 1 negatively regulates somatic hypermutation
por: Frankenberger, Samantha, et al.
Publicado: (2014)

Ultradeep analysis of tumor heterogeneity in regions of somatic hypermutation
por: Spence, Janice M, et al.
Publicado: (2015)

Restriction of AID activity and somatic hypermutation by PARP-1
por: Tepper, Sandra, et al.
Publicado: (2019)

Topologically Associated Domains Delineate Susceptibility to Somatic Hypermutation
por: Senigl, Filip, et al.
Publicado: (2019)

An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain
por: Wu, Nicholas C., et al.
Publicado: (2020)

The IgH 3′ regulatory region controls somatic hypermutation in germinal center B cells
por: Rouaud, Pauline, et al.
Publicado: (2013)

Somatic Hypermutation Introduces Insertions and Deletions into Immunoglobulin V Genes
por: Wilson, Patrick C., et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_smete8ibu8kchfptm673e9lmfo